Nancy Chang Overview
- Investor Type
- Angel
- Investments
- 2
- Portfolio
- 2
Nancy Chang General Information
Description
Dr. Nancy Chang serves as Chief Executive Officer & Chairperson of the Board at Ansun Biopharma. Nancy was the Chairperson and Senior Managing Director of Caduceus Asia Partners at OrbiMed Advisors from 2007 to 2012. From 1987 to 2007, Dr. Chang served as Co-Founder, President and Chairman of Tanox, Inc., which was sold to Genentech in 2007. Prior to founding Tanox, Dr. Chang held several leadership positions at Centocor, now a division of Johnson & Johnson. She was also an Associate Professor at Baylor College of Medicine. She has served on the board of a number of companies, including SciClone Pharmaceuticals, Inc., Charles River Laboratories International, Inc., Applied Optoelectronics Inc. Nancy received her Doctorate in Biological Chemistry from Harvard University.
Contact Information
Primary Investor Type
Angel (individual)
Primary Office
- 3030 Callan Road
- San Diego, CA 92121
- United States
+1 (858) 000-0000
Nancy Chang Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Rgenix | 31-Jul-2015 | Early Stage VC | 000 | Drug Discovery | Clinical Trials - Phase 2 | 00000 00000 00.0 |
| 0000000 | 19-Jun-2015 | 00000 00000 | 00.00 | Monitoring Equipment | Generating Revenue | 00000 00000 00.0 |
Nancy Chang Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialNancy Chang Team (1)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Nancy Chang Ph.D | Angel Investor | 0 | 0 | 0 | San Diego, CA |